Stabilization and Assessment at New Haven

Stabilization and Assessment at New Haven is a SAMHSA-registered addiction-treatment facility in Spanish Fork, UT. The facility offers specific levels of care: Inpatient, Dual Dx. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Stabilization and Assessment at New Haven

The facility's documented care levels are The facility offers specific levels of care: Inpatient, Dual Dx. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. ASAM Criteria 4e is the benchmark framework for matching patients to appropriate intensity. Most major payer medical-necessity documents reference it. An outside ASAM-aligned assessment, prior to admission, is the protection against misplacement.

Insurance and payment

Stabilization and Assessment at New Haven operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Specialty programming

The facility's documented specialty programming includes: Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma, Persons with eating disorders. Evaluating specialty capacity requires asking specifically: what clinicians deliver the specialty content, with what credentials, for how many hours per week. Marketing designation without documented clinical infrastructure is a recognized pattern worth filtering out.

Before you call

Three pre-admission questions for Stabilization and Assessment at New Haven: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Stabilization and Assessment at New Haven offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.